These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14715852)

  • 1. Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease?
    Gunnell D; Oliver SE; Donovan JL; Peters TJ; Gillatt D; Persad R; Hamdy FC; Neal DE; Holly JM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):213-8. PubMed ID: 14715852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of childhood and adulthood height and the components of height with insulin-like growth factor levels in adulthood: a 65-year follow-up of the Boyd Orr cohort.
    Bray I; Gunnell D; Holly JM; Middleton N; Davey Smith G; Martin RM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1382-9. PubMed ID: 16434460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort.
    Martin RM; Holly JM; Davey Smith G; Gunnell D
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3287-95. PubMed ID: 16787980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
    Ong K; Kratzsch J; Kiess W; Costello M; Scott C; Dunger D
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4266-9. PubMed ID: 11095465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
    Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population.
    Martin RM; Gunnell D; Whitley E; Nicolaides A; Griffin M; Georgiou N; Davey Smith G; Ebrahim S; Holly JM
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1331-8. PubMed ID: 18211967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature.
    Rooman RP; De Beeck LO; Martin M; van Doorn J; Mohan S; Du Caju MV
    Eur J Endocrinol; 2005 Apr; 152(4):597-604. PubMed ID: 15817916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the IGF system in 15 patients with Alström syndrome.
    Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children.
    Garrone S; Radetti G; Sidoti M; Bozzola M; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5455-60. PubMed ID: 12466336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates.
    Lo HC; Tsao LY; Hsu WY; Chen HN; Yu WK; Chi CY
    Nutrition; 2002; 18(7-8):604-8. PubMed ID: 12093439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.
    Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S
    Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis.
    Neidel J
    Clin Exp Rheumatol; 2001; 19(1):81-4. PubMed ID: 11247331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
    Krassas GE; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen JW; Flyvbjerg A
    J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.